Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer cells and T-cells are two major types of lymphocytes that together orchestrate critical functions of the immune system. NK cells belong to the innate immune arm, providing rapid, non-specific cytotoxic responses against infected or transformed cells through receptor-mediated recognition and release of lytic granules[4][5][8]. T-cells, major contributors to adaptive immunity, use specialized T-cell receptors (TCR) to recognize antigen-MHC complexes, resulting in targeted cytotoxicity (by CD8+ T-cells) and immune regulation (by CD4+ T-cells)[1][7]. Both types are vital for host defense against infection and cancer and are frequent targets of immunotherapeutic interventions[6][8]. Entry as "NK cells and T-cells" is imprecise and should be split for accurate molecular annotation.
Direct cytotoxicity (granzyme, perforin-mediated killing); Cytokine modulation (activation/suppression of immune pathways); Death receptor-induced apoptosis (FasL, TRAIL); Immune checkpoint modulation (inhibition/activation of signaling pathways)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NK cells and T-cells (NK cells; T-cells).